(NASDAQ: BWAY) Brainsway's forecast annual revenue growth rate of 35.19% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 11.73%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Brainsway's revenue in 2023 is $29,614,000.On average, 4 Wall Street analysts forecast BWAY's revenue for 2023 to be $1,290,319,921, with the lowest BWAY revenue forecast at $1,263,109,321, and the highest BWAY revenue forecast at $1,313,499,320. On average, 1 Wall Street analysts forecast BWAY's revenue for 2024 to be $1,857,711,315, with the lowest BWAY revenue forecast at $1,857,711,315, and the highest BWAY revenue forecast at $1,857,711,315.
In 2025, BWAY is forecast to generate $2,321,299,310 in revenue, with the lowest revenue forecast at $2,321,299,310 and the highest revenue forecast at $2,321,299,310.